2025-521480-12-00CompletedPhase 1
A Phase 1 Study of ATV-1601, in Patients with Advanced Cancer that have AKT1 E17K Mutations
Source: EU CTIS (euclinicaltrials.eu) · Last updated 1 Apr 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (actual)
- First submitted
- 10 Jun 2025
- Start date
- 22 Oct 2025
- Lead sponsor
- Atavistik Bio Inc.
- Diseases
- Metastatic breast cancer
- EU CT number
- 2025-521480-12-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 64
- 15 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (15)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Jules Bordet | Anderlecht | Belgium | Completed |
| UZ Leuven | Leuven | Belgium | Completed |
| Hospital HM Nou Delfos | Barcelona | Spain | Completed |
| Hospital Clinic de Barcelona | Barcelona | Spain | Completed |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Completed |
| Hospital Universitario HM Sanchinarro | Madrid | Spain | Completed |
| Hospital Universitario 12 de Octubre | Madrid | Spain | Completed |
| Hospital Universitario Fundación Jiménez Díaz | Madrid | Spain | Completed |
| Hospital Clinico Universitario de Valencia | Valencia | Spain | Completed |
| Institut Bergonie | Bordeaux | France | Completed |
| Centre Leon Berard | Lyon | France | Completed |
| Institut Curie | Paris | France | Completed |
| Oncopole Claudius Regaud | Toulouse Cedex 9 | France | Completed |
| Istituto Europeo di Oncologia s.r.l | Milan | Italy | Completed |
| IRCCS Istituto Nazionale Tumori Fondazione Pascale | Naples | Italy | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.